Literature DB >> 12221149

Mechanisms of pain modulation in chronic syndromes.

Hayrunnisa Bolay1, Michael A Moskowitz.   

Abstract

Transmission of pain from the periphery to the cortex depends on integration and signal processing within the spinal cord, brainstem, and forebrain. Sensitization, a component of persistent or chronic pain, may develop either through peripheral mechanisms or as a consequence of altered physiology in the spinal cord or forebrain. Several molecular and biophysical mechanisms contribute to the phenomenon of sensitization and persistent pain, including upregulation of sensory neuron-specific sodium channels and vanilloid receptors, phenotypic switching of large myelinated axons, sprouting within the dorsal horn, and loss of inhibitory neurons due to apoptotic cell death. Recently, forebrain structures have been implicated in the pathophysiology of persistent pain. Although a number of treatment options are used, unfortunately pharmacotherapy for neuropathic pain is often ineffective. Unraveling the mysteries of chronic pain may lead to better treatment options, such as drugs that act specifically on sensory neuron-specific sodium channels or as NR2B-subunit-selective N-methyl-D-aspartate receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12221149     DOI: 10.1212/wnl.59.5_suppl_2.s2

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  32 in total

1.  Ionic mechanisms underlying inflammatory mediator-induced sensitization of dural afferents.

Authors:  Andrea H Vaughn; Michael S Gold
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

Review 2.  Herpes simplex virus-based vectors.

Authors:  Robin Lachmann
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

3.  Lack of positive allosteric modulation of mutated alpha(1)S267I glycine receptors by cannabinoids.

Authors:  Nilufar Foadi; Martin Leuwer; Reyhan Demir; Reinhard Dengler; Vanessa Buchholz; Jeanne de la Roche; Matthias Karst; Gertrud Haeseler; Jörg Ahrens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-26       Impact factor: 3.000

Review 4.  "Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Erin D Milligan; Steven F Maier
Journal:  Brain Res Rev       Date:  2007-07-13

Review 5.  The role of chemosensitive afferent nerves and TRP ion channels in the pathomechanism of headaches.

Authors:  Mária Dux; Péter Sántha; Gábor Jancsó
Journal:  Pflugers Arch       Date:  2012-08-09       Impact factor: 3.657

6.  Peripheral and Central Sensitization of Pain in Individuals With Hand Osteoarthritis and Associations With Self-Reported Pain Severity.

Authors:  Pernille Steen Pettersen; Tuhina Neogi; Karin Magnusson; Hilde Berner Hammer; Till Uhlig; Tore K Kvien; Ida K Haugen
Journal:  Arthritis Rheumatol       Date:  2019-05-14       Impact factor: 10.995

Review 7.  Management of chronic arthritis pain in the elderly.

Authors:  Mary-Ann Fitzcharles; David Lussier; Yoram Shir
Journal:  Drugs Aging       Date:  2010-06-01       Impact factor: 3.923

8.  Two mechanisms involved in trigeminal CGRP release: implications for migraine treatment.

Authors:  Paul L Durham; Caleb G Masterson
Journal:  Headache       Date:  2012-10-23       Impact factor: 5.887

9.  Positive allosteric modulatory effects of ajulemic acid at strychnine-sensitive glycine alpha1- and alpha1beta-receptors.

Authors:  Jörg Ahrens; Martin Leuwer; Reyhan Demir; Klaus Krampfl; Jeanne de la Roche; Nilufar Foadi; Matthias Karst; Gertrud Haeseler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-11-05       Impact factor: 3.000

Review 10.  Clinical experience with duloxetine in the management of chronic musculoskeletal pain. A focus on osteoarthritis of the knee.

Authors:  Jacques P Brown; Luc J Boulay
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-12       Impact factor: 5.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.